Posted inCardiology Critical Care news
Refining Patient Selection for Microaxial Flow Pumps: The DanGer Shock-like Profile as a Survival Predictor in STEMI-CS
This study validates the DanGer Shock trial criteria in a real-world registry, demonstrating that patients matching the trial's profile have significantly better survival outcomes when treated with microaxial flow pumps compared to those who do not meet these specific clinical markers.